Integral Ad Science (NASDAQ:IAS) Cut to “Hold” at Baird R W

Integral Ad Science (NASDAQ:IAS) was downgraded by equities research analysts at Baird R W from a “strong-buy” rating to a “hold” rating in a research report issued on Friday,Zacks.com reports.

A number of other equities analysts also recently weighed in on the stock. Barclays restated an “equal weight” rating on shares of Integral Ad Science in a report on Friday, February 28th. Robert W. Baird restated a “neutral” rating and set a $9.00 price objective (down from $16.00) on shares of Integral Ad Science in a research note on Friday. Truist Financial raised their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Monday, March 3rd. Scotiabank initiated coverage on Integral Ad Science in a research report on Friday, February 28th. They set a “sector perform” rating and a $12.00 price target on the stock. Finally, Morgan Stanley reaffirmed a “mixed” rating on shares of Integral Ad Science in a research report on Monday, March 3rd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Integral Ad Science has a consensus rating of “Moderate Buy” and a consensus target price of $14.45.

Integral Ad Science Stock Down 4.6 %

Shares of IAS stock opened at $8.24 on Friday. The firm’s fifty day moving average price is $10.01 and its two-hundred day moving average price is $10.55. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science has a 1 year low of $7.98 and a 1 year high of $13.62. The firm has a market capitalization of $1.35 billion, a P/E ratio of 41.20, a PEG ratio of 1.06 and a beta of 1.45.

Integral Ad Science (NASDAQ:IAS) last released its earnings results on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. During the same period in the prior year, the firm posted $0.06 EPS. Integral Ad Science’s revenue was up 13.9% compared to the same quarter last year. On average, equities analysts predict that Integral Ad Science will post 0.26 EPS for the current fiscal year.

Insider Activity at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 12,448 shares of the company’s stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total transaction of $132,073.28. Following the completion of the sale, the chief executive officer now owns 278,650 shares of the company’s stock, valued at approximately $2,956,476.50. This represents a 4.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders sold 19,109 shares of company stock worth $197,696. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in IAS. Alyeska Investment Group L.P. bought a new position in shares of Integral Ad Science in the 4th quarter valued at $41,543,000. Dimensional Fund Advisors LP grew its position in Integral Ad Science by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company’s stock valued at $39,567,000 after acquiring an additional 580,323 shares during the last quarter. Clearline Capital LP acquired a new position in Integral Ad Science during the fourth quarter worth about $3,949,000. Invenomic Capital Management LP lifted its holdings in shares of Integral Ad Science by 52.9% in the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company’s stock worth $9,344,000 after acquiring an additional 309,752 shares during the last quarter. Finally, Ararat Capital Management LP boosted its stake in shares of Integral Ad Science by 13.4% in the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company’s stock valued at $23,823,000 after purchasing an additional 269,346 shares in the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.